Malcolm Salter - 18 Jun 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
18 Jun 2021
Net transactions value
-$28,078
Form type
4
Filing time
21 Jun 2021, 20:23:07 UTC
Previous filing
17 Jun 2021
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Sale $28,078 -755 -4.8% $37.19* 14,843 18 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.